Heart Assist Transport device
Search documents
Xvivo Perfusion AB (publ) (XVIPY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha· 2026-01-15 05:15
Company Overview - XVIVO is focused on advancing organ care prior to transplantation, aiming to reduce mortality caused by organ failure [2] - The company's vision is to ensure that no one dies waiting for an organ [2] Technology Impact - XVIVO's technology has enabled patients, such as Alex from a remote town in Australia, to receive organs from distant locations, which was previously impossible [3] - The Heart Assist Transport device is a key innovation that facilitates organ transport across long distances [3] Mission and Vision - The company operates under the principle that organ care should occur outside the body, aligning with its name XVIVO, which means "outside the body" [4]